Ginkgo Q2 revenue down 48% to $20M; wins govt contracts for autonomous labs at MIT, Caltech, Northwestern

Ginkgo Bioworks Holdings, Inc.

Q2 revenue $20M vs $39M YoY; GAAP net loss from continuing ops ($57M) vs ($53M).
Adjusted EBITDA ($36M) vs ($25M); cash and equivalents $302M as of June 30.
Won contracts to build autonomous labs at MIT, Caltech, Northwestern, U of Maryland under NSF's ~$400M cloud lab network.
New ADME-One service claims 10X cost advantage over WuXi, signed 17 customers in first 6 weeks.
Reaffirms FY 2026 total cash burn guidance of ($150)-($125)M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.